| Index | Ligand Name | Structure | PDB code | Compound Potency nM |
| 1 | ezt | Crystal structure of the ER alpha ligand binding domain with the agonist ortho-trifluoromethylphenylvinyl estradiol | 2p15 | 0.05 |
| 2 | des | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DIETHYLSTILBESTROL AND A GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1 NR BOX II PEPTIDE | 3erd | 0.126 |
| 3 | est | ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL | 1a52 | 0.138 |
| 4 | oht | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH 4-HYDROXYTAMOXIFEN | 3ert | 0.249 |
| 5 | wst | Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold. | 2pog | 0.29 |
| 6 | llc | Estrogen receptor alpha ligand-binding domain in complex with a SERM | 2r6y | 0.32 |
| 7 | aiu | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 16 | 1xp6 | 0.4 |
| 8 | llb | Estrogen receptor alpha ligand-binding domain complexed to a SERM | 2r6w | 0.44 |
| 9 | aih | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 15 | 1xp1 | 0.5 |
| 10 | l4g | A SERM Designed for the Treatment of Uterine Leiomyoma with Unique Tissue Specificity for Uterus and Ovaries in Rats | 2ayr | 0.51 |
| 11 | e4d | Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D | 1sj0 | 0.8 |
| 12 | est | MUTANT ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL | 1qkt | 0.92 |
| 13 | iok | Human estrogen receptor alpha ligand-binding domain in complex with compound 1D | 2iok | 1 |
| 14 | aij | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 18 | 1xp9 | 1.3 |
| 15 | est | The Estrogen Receptor Alpha Ligand Binding Domain D538G Mutant in Complex with Estradiol and a glucocorticoid receptor-interacting protein 1 NR box II peptide | 4pxm | 1.3 |
| 16 | ait | HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH COMPOUND 19 | 1xpc | 1.7 |
| 17 | i0g | Benzopyrans are Selective Estrogen Receptor beta Agonists (SERBAs) with Novel Activity in Models of Benign Prostatic Hyperplasia | 2i0j | 2.68 |
| 18 | 85z | Oxyphenylpropenoic acids as Oral Selective Estrogen Receptor Down- Regulators. | 5ak2 | 3.9 |
| 19 | ral | HUMAN ESTROGEN RECEPTOR LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE | 1err | 7.7 |
| 20 | iog | Human estrogen receptor alpha ligand-binding domain in complex with compound 11F | 2iog | 8 |
| 21 | dc8 | Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand | 2q70 | 8.3 |
| 22 | gen | CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN | 1x7r | 9 |
| 23 | jj3 | Estrogen receptor alpha ligand-binding domain in complex with a benzopyran agonist | 2qe4 | 11 |
| 24 | 77w | ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-{4-[(1R)-2-(4-fluorophenyl)-6-hydroxy-1-methy l-1,2,3,4- tetrahydroisoquinolin-1-yl]phenyl}prop-2-enoic acid | 5t92 | 16 |
| 25 | 782 | ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-(4-{(1R)-6-hydroxy-1-methyl-2-[4-(propan-2 -yl)phenyl]-1,2,3,4- tetrahydroisoquinolin-1-yl}phenyl)prop-2-enoic acid | 5t97 | 17 |
| 26 | pti | The Structure of Estrogen Receptor in Complex with a Selective and Potent Tetrahydroisochiolin Ligand. | 1uom | 19 |
| 27 | gqd | Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 1. | 5fqp | 19 |
| 28 | qhg | Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 2. | 5fqr | 26 |
| 29 | j0w | Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 3. | 5fqs | 44 |
| 30 | aej | X-ray structure of ERalpha LBD bound to a tetrahydroisoquinoline SERM ligand at 2.05A resolution | 1xqc | 63 |
| 31 | 17m | Human estrogen receptor alpha ligand-binding domain in complex with 17methyl-17alpha-dihydroequilenin and a glucoc interacting protein 1 NR box II peptide | 2b1z | 79 |
| 32 | 7qn | Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 4. | 5fqt | 160 |
| 33 | 27j | Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalanol | 4mg8 | 330 |
| 34 | 27h | Crystal structure of hERa-LBD (Y537S) in complex with ferutinine | 4mg7 | 440 |
| 35 | 27m | Crystal structure of hERa-LBD (Y537S) in complex with benzophenone-2 | 4mgc | 480 |
| 36 | est | CRYSTAL STRUCTURE OF A WILD TYPE HER ALPHA LBD AT 2.9 ANGSTROM RESOLUTION | 1g50 | 530 |
| 37 | 459 | Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-2M and A Glucocorticoid Receptor Interacting Protein 1 NR Box II Peptide | 2fai | 570 |
| 38 | vqi | Selective estrogen receptor downregulator antagonists: Tetrahydroisoquinoline phenols 5. | 5fqv | 610 |
| 39 | gen | Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein | 2qa8 | 990 |
| 40 | 27g | Crystal structure of hERa-LBD (Y537S) in complex with benzylbutylphtalate | 4mg6 | 2420 |